Efficacy Study of Cyclosporine Ophthalmic Emulsion in Patients With Dry Eye Disease

Completed

Conditions studied: Keratoconjunctivitis Sicca

In brief

This study will evaluate the efficacy of cyclosporine ophthalmic solution vs. other non-prescription treatments in patients with dry eye disease. Patient and physician assessments completed at baseline, at each follow-up visit (follow-up visits are variable as per physician discretion) and at final follow-up visit.

Key facts

Study ID

NCT00717418

Run by

Allergan

People needed

781

Starts

2004-09-01

Expected to finish

2008-08-01

Last updated by the study team

2012-01-12

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of dry eye disease
• Currently using artificial tears daily
• Male or female of legal age of consent
• Normal lid position and closure

You may not qualify if…

• Patients currently using cyclosporine ophthalmic emulsion 0.05%
• Participation in other investigational drug or device study
• Any current or previous topical ophthalmic or oral cyclosporine use within the last three years

Where it is running

• Study site — Wilson, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.